» Articles » PMID: 35281144

Assessment of Podoplanin Lymphatic Vessel Density in Oral Epithelial Dysplasia

Overview
Date 2022 Mar 14
PMID 35281144
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral squamous cell carcinoma (OSCC) can be preceded by the appearance of lesions which have the potential to develop into cancer. Recently, it was suggested that the tumor-associated lymphatic vessels formation plays an active role in tumor progression and metastasis of several human malignancies including OSCC. There is the view that, in an individual lesion, the more severe the dysplasia, the greater the likelihood is of progression to malignancy.

Aim: This study is aimed to investigate podoplanin (PDPN) immunoexpression in lymphatic vessels of oral epithelial dysplasia (OED) and to assess the lymphatic vessel density (LVD) in histologic grades of OED.

Materials And Methods: The study group comprised thirty histopathologically diagnosed cases of OED with various grades of differentiation and thirty cases of clinically normal oral mucosa. After immunohistochemical staining, cases of OED were immunohistochemically analyzed quantitatively for PDPN (D2-40) LVD.

Statistical Analysis: The statistical analysis was done using Kruskal Wallis analysis of variance; pair-wise Tukey's test was applied to evaluate the significant differences among the mean values in different groups. Results with " < 0.05" were considered to be statistically significant at 95% of confidence level.

Results: PDPN LVD scores increased with increasing grades of dysplasia. Pair-wise comparisons of the PDPN LVD scores and the histopathologic grades of OED were found to be statistically significant ( < 0.05).

Conclusions: Increase in PDPN LVD in OED represents a promising tool for more wide spread studies of tumor lymphangiogenesis and its role in progression of dysplastic lesion to human cancer.

Citing Articles

Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.

Zdrojewski J, Nowak M, Nijakowski K, Jankowski J, Scribante A, Gallo S Biomedicines. 2024; 12(3).

PMID: 38540190 PMC: 10967812. DOI: 10.3390/biomedicines12030577.


Lymph Vessels Associate with Cancer Stem Cells from Initiation to Malignant Stages of Squamous Cell Carcinoma.

Cazzola A, Calzon Lozano D, Menne D, Davila Pedrera R, Liu J, Pena-Jimenez D Int J Mol Sci. 2023; 24(17).

PMID: 37686421 PMC: 10488284. DOI: 10.3390/ijms241713615.


A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.

Srinivasan V, Shyam N, Kiran Kumar G, Narayen V, Konda P, Swetha Rani K Cureus. 2023; 15(5):e38467.

PMID: 37273383 PMC: 10238285. DOI: 10.7759/cureus.38467.


Immunohistochemical visualization of lymphatic vessels in human dura mater: methodological perspectives.

Quesada C, Rao S, Torp R, Eide P Fluids Barriers CNS. 2023; 20(1):23.

PMID: 36978127 PMC: 10044429. DOI: 10.1186/s12987-023-00426-3.


Oral epithelial dysplasia and aphthous ulceration in a patient with ulcerative colitis: a case report.

Sun K, Xia R BMC Oral Health. 2023; 23(1):143.

PMID: 36906558 PMC: 10007854. DOI: 10.1186/s12903-023-02851-0.

References
1.
Reibel J . Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003; 14(1):47-62. DOI: 10.1177/154411130301400105. View

2.
de Vicente J, Rodrigo J, Rodriguez-Santamarta T, Lequerica-Fernandez P, Allonca E, Garcia-Pedrero J . Podoplanin expression in oral leukoplakia: tumorigenic role. Oral Oncol. 2013; 49(6):598-603. DOI: 10.1016/j.oraloncology.2013.02.008. View

3.
Wicki A, Christofori G . The potential role of podoplanin in tumour invasion. Br J Cancer. 2006; 96(1):1-5. PMC: 2360213. DOI: 10.1038/sj.bjc.6603518. View

4.
Schacht V, Dadras S, Johnson L, Jackson D, Hong Y, Detmar M . Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005; 166(3):913-21. PMC: 1602360. DOI: 10.1016/S0002-9440(10)62311-5. View

5.
Ohta M, Abe A, Ohno F, Hasegawa Y, Tanaka H, Maseki S . Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Oral Oncol. 2012; 49(1):20-6. DOI: 10.1016/j.oraloncology.2012.06.017. View